Schedule 13D ownership disclosure

Phathom Pharmaceuticals Inc

Security class unavailable · CUSIP: 71722W107

Event date: 2021-04-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,672,000
Percent of class
22.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001395064-21-000053
Form type
SC 13D/A
Filer
Phathom Pharmaceuticals, Inc.
CIK
CIK 1783183
Filed
Apr 06, 2021
Reporting period
Apr 02, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub